![Fahed Al Marzooqi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fahed Al Marzooqi
Director/Board Member at VTV THERAPEUTICS INC.
Net worth: 14 581 $ as of 2024-05-30
Fahed Al Marzooqi active positions
Companies | Position | Start | End |
---|---|---|---|
VTV THERAPEUTICS INC. | Director/Board Member | 2022-07-10 | - |
Independent Dir/Board Member | 2022-07-10 | - | |
G42 Healthcare
![]() G42 Healthcare Information Technology ServicesTechnology Services Part of Mubadala Healthcare, G42 Healthcare is an Emirati company that uses advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conduct research into new vaccines and drug therapies, and map trends in the outbreak including virus mutations. The company is based in Masdar, United Arab Emirates. The company is committed to harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care, while transforming the traditional healthcare ecosystem. G42 Healthcare established Biogenix Labs, the UAE's first COVID-19 accredited large-scale throughput laboratory, and facilitated the #4Humanity clinical trials, the world's first phase III trials for an inactivated vaccine against COVID-19. The company plans to conduct research and development on genomics, imaging and diagnostics, and digitization programs to support the health of future generations. The CEO of the company is Ashish Koshy. G42 Healthcare was acquired by Mubadala Healthcare on October 06, 2022. | Chief Operating Officer | - | - |
Career history of Fahed Al Marzooqi
Former positions of Fahed Al Marzooqi
Companies | Position | Start | End |
---|---|---|---|
Cleveland Clinic Abu Dhabi
![]() Cleveland Clinic Abu Dhabi Hospital/Nursing ManagementHealth Services Cleveland Clinic Abu Dhabi engages in the provision of health care services. It provides heart & vascular, neurological, digestive disease, eye, respiratory, and critical care services. The firm also provides surgical subspecialties, medical subspecialties, emergency medicine, anesthesiology, pathology & laboratory medicine, and imaging services. The company was founded in 2006 and is headquartered in Abu Dhabi, United Arab Emirates. | Chief Administrative Officer | - | - |
Training of Fahed Al Marzooqi
Dalhousie University | Graduate Degree |
Statistics
International
United Arab Emirates | 3 |
Canada | 2 |
United States | 2 |
Operational
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Chief Operating Officer | 1 |
Sectoral
Consumer Services | 2 |
Health Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VTV THERAPEUTICS INC. | Health Technology |
Private companies | 2 |
---|---|
Cleveland Clinic Abu Dhabi
![]() Cleveland Clinic Abu Dhabi Hospital/Nursing ManagementHealth Services Cleveland Clinic Abu Dhabi engages in the provision of health care services. It provides heart & vascular, neurological, digestive disease, eye, respiratory, and critical care services. The firm also provides surgical subspecialties, medical subspecialties, emergency medicine, anesthesiology, pathology & laboratory medicine, and imaging services. The company was founded in 2006 and is headquartered in Abu Dhabi, United Arab Emirates. | Health Services |
G42 Healthcare
![]() G42 Healthcare Information Technology ServicesTechnology Services Part of Mubadala Healthcare, G42 Healthcare is an Emirati company that uses advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conduct research into new vaccines and drug therapies, and map trends in the outbreak including virus mutations. The company is based in Masdar, United Arab Emirates. The company is committed to harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care, while transforming the traditional healthcare ecosystem. G42 Healthcare established Biogenix Labs, the UAE's first COVID-19 accredited large-scale throughput laboratory, and facilitated the #4Humanity clinical trials, the world's first phase III trials for an inactivated vaccine against COVID-19. The company plans to conduct research and development on genomics, imaging and diagnostics, and digitization programs to support the health of future generations. The CEO of the company is Ashish Koshy. G42 Healthcare was acquired by Mubadala Healthcare on October 06, 2022. | Technology Services |
- Stock Market
- Insiders
- Fahed Al Marzooqi
- Experience